An Infection Model for SARS-CoV-2 Using Rat Transplanted with hiPSC-Airway Epithelial Cells
Tissue Engineering Part A · 2025
DOI: 10.1089/ten.tea.2024.0016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part A, 2025. Verfasst von Masayuki Kitano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Graduate School of medicine, Kyoto University, Kyoto City, Japan. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Disease Models, Animal, SARS-CoV-2, COVID-19. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Investigating the infection mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the airway epithelium and developing effective defense strategies against infection are important. To achieve this, establishing appropriate infection models is crucial. Therefore, various in vitro models, such as cell lines and primary cultures, and in vivo models involving animals that exhibit SARS-CoV-2 infection and genetically humanized animals have been used as animal models. However, no animal model has been established that allows infection experiments with human cells under the physiological environment of airway epithelia. Therefore, we aimed to establish a novel animal model that enables infection experiments using human cells. Human induced pluripotent stem cell-derived airway epithelial cell-transplanted nude rats (hiPSC-AEC rats) were used, and infection studies were performed by spraying lentiviral pseudoviruses containing SARS-CoV-2 spike protein and the GFP gene on the tracheae. After infection, immunohistochemical analyses revealed the existence of GFP-positive-infected transplanted cells in the epithelial and submucosal layers. In this study, a SARS-CoV-2 infection animal model including human cells was established mimicking infection through respiration, and we demonstrated that the hiPSC-AEC rat could be used as an animal model for basic research and the development of therapeutic methods for human-specific respiratory infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Graduate School of medicine, Kyoto University, Kyoto City, Japan.
- Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto City, Japan.
- Department of Molecular and Cellular Physiology, Research Institute for Cell Design Medical Science, Graduate School of Medicine, Yamaguchi University, Ube City, Japan.
- Department of Otolaryngology, Kobe City Medical Center General Hospital, Kobe city, Japan.
ORCID-Profile: Masayuki Kitano, Hiroe Ohnishi, Yasuyuki Hayashi, Keisuke Mizuno, Norio Yamamoto
Zitieren
APA
Kitano, M., Ohnishi, H., Makino, A., Miyamoto, T., Hayashi, Y., Mizuno, K., Kaba, S., Kawai, Y., Kojima, T., Kishimoto, Y., Yamamoto, N., Tomonaga, K., & Omori, K. (2025). An Infection Model for SARS-CoV-2 Using Rat Transplanted with hiPSC-Airway Epithelial Cells. Tissue Engineering Part A. https://doi.org/10.1089/ten.tea.2024.0016
Vancouver
Kitano M, Ohnishi H, Makino A, Miyamoto T, Hayashi Y, Mizuno K, et al. An Infection Model for SARS-CoV-2 Using Rat Transplanted with hiPSC-Airway Epithelial Cells. Tissue Engineering Part A. 2025. doi:10.1089/ten.tea.2024.0016
BibTeX
@article{Kitano2025,
author = {Kitano, Masayuki and Ohnishi, Hiroe and Makino, Akiko and Miyamoto, Tatsuo and Hayashi, Yasuyuki and Mizuno, Keisuke and Kaba, Shinji and Kawai, Yoshitaka and Kojima, Tsuyoshi and Kishimoto, Yo and Yamamoto, Norio and Tomonaga, Keizo and Omori, Koichi},
title = {An Infection Model for SARS-CoV-2 Using Rat Transplanted with hiPSC-Airway Epithelial Cells},
journal = {Tissue Engineering Part A},
year = {2025},
doi = {10.1089/ten.tea.2024.0016}
}
EUVIMED